Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000930413-11-001936
Filing Date
2011-03-16
Accepted
2011-03-16 17:28:48
Documents
10
Period of Report
2010-12-31

Document Format Files

Seq Description Document Type Size
1 c64669_10k.htm 10-K 1305147
2 GRAPHIC c56802xenzonlogoxk.jpg GRAPHIC 4525
3 GRAPHIC c64669xgraph.jpg GRAPHIC 16324
4 c64669_ex12-1.htm EX-12.1 32576
5 c64669_ex21-1.htm EX-21.1 2483
6 c64669_ex23-1.htm EX-23.1 1998
7 c64669_ex31-1.htm EX-31.1 11655
8 c64669_ex31-2.htm EX-31.2 11649
9 c64669_ex32-1.htm EX-32.1 4222
10 c64669_ex32-2.htm EX-32.2 4182
  Complete submission text file 0000930413-11-001936.txt   1404268
Mailing Address 685 ROUTE 202/206 ATT: GENERAL COUNSEL BRIDGEWATER NJ 08807
Business Address 685 ROUTE 202/206 BRIDGEWATER NJ 08807 908 541 8671
ENZON PHARMACEUTICALS INC (Filer) CIK: 0000727510 (see all company filings)

EIN.: 222372868 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-12957 | Film No.: 11692956
SIC: 2836 Biological Products, (No Diagnostic Substances)